References
- Wheeler S. D., Carrazana E. J. Topriamate‐treated cluster headache. Neurology 1999; 53(1)234–236
- Galvez‐Jimenez N., Hargreave M. Topiramate and essential tremor. Ann Neurol 2000; 47(6)837–838
- Appolinario J. C., Coutinho W., Fontenelle L. Topiramate for binge eating disorder. Am J Psychiatry 2001; 158(6)967–968
- Normann C., Langosch J., Schaerer L. O., Grunze H., Walden J. Treatment of acute mania with topiramate. Am J Psychiatry 1999; 156(12)2014
- Abuzzahab F. S., Brown V. L. Control of Tourette's syndrome with topiramate. Am J Psychiatry 2001; 158(6)98
- Glauser TA. Topiramate. Epilepsia 1999; 40(S5)S71–S80
- Privitera M. D. Topiramate: a new antiepileptic drug. Ann Pharcother 1997; 31: 1164–1173
- Wilner A., Raymond K., Pollard R. Topiramate and metabolic acidosis. Epilepsia 1999; 40(6)792–795
- Ko C‐H., Kong C‐K. Topiramate‐induced metabolic acidosis: report of two cases. Dev Med Child Neurol 2001; 43: 701–704
- Jones M. W. Topiramate—safety and tolerability. Can J Neurol Sci 1998; 25: S13–S15
- Sankar P. S., Pasquale L. R., Grosskreutz C. L. Uveal effusion and secondary angle‐closure glaucoma associated with topiramate use. Arch Ophthamol 2001; 119: 1210–1211
- Banta J. T., Hoffman K., Budenz D. L., Ceballos E., Greenfield D. S. Presumed topiramate‐induced bilateral acute angle‐closure glaucoma. Am J Ophthamol 2001; 132(1)112–114
- Rhee D. J., Goldberg M. J., Parrish R. K. Bilateral angle‐closure glaucoma and ciliary body swelling from topiramate. Arch Ophthamol 2001; 119: 1721–1722
- Sen H. A., O'Halloran H. S., Lee W. B. Topiramate‐induced acute myopia and retinal striae. Arch Opthamol 2001; 119: 775–777
- Grinbaum A. G., Ashkenazi I., Gutman I., Blumenthal M. Suggested mechanism for acute transient myopia after sulfonamide treatment. Ann Opthalmol 1993; 25: 224–226
- Doan R. J., Clendenning M. Topiramate and hepatotoxicity. Can J Psychiatry 2000; 45(10)937–938
- Bjoro K., Gjerstad L., Bentdal O., Osnes S., Schrumpf E. Topiramate and fulminant liver failure. Lancet 1998; 352(9134)1119
- Aldenkamp A. P., Baker G., Mulder O. G., Chadwick D., Cooper P., Doelman J., Duncan R., Gassman‐Mayer C., de Haan G. J., Hughson C., Hulsman J., Overweg J., Pledger G., Rentmeester T. W., Riaz H., Wroe S. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add‐on therapy to carbamazepine in patients with partial‐onset seizures. Epilepsia 2000; 41(9)1167–1178
- Davanzo P., Cantwell E., Kleiner J., Baltaxde C., Najera B., Crecelius G., McCraker J. Cognitive changes during topiramate therapy. J Am Acad Child Adolesc Psychiatry 2001; 40(3)262–263
- Martin R., Kuzniecky R., Ho S., Heterington H., Pan J., Sinclair K., Gillam F., Faught E. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999; 52(2)321–327
- Thompson P. J., Baxendale S. A., Duncan J. S., Sander J. W. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry 2000; 69(5)636–641
- Andrade C. Confusion and dysphoria with low‐dose topiramate in a patient with bipolar disorder. Bipolar Disord 2001; 3(4)211–212
- Burton L. A., Harden C. Effect of topiramate on attention. Epilepsy Res 1997; 27(1)29–32
- Young W. B., Hopkins M. M., Schechter A. L., Silberstein S. D. Topiramate: a case series study in migraine prophylaxis. Cephalalgia 2002; 22(8)659–663
- Levisohn P. M. Safety and tolerability of topiramate in children. J Child Neurol 2000; 15(suppl 1)S22–S26
- Silberstein S. D. Control of topiramate‐induced paresthesias with supplemental potassium. Headache 2002; 42(1)85
- Stephen L. J., Maxwell J. E., Brodie M. J. Transient hemiparesis with topiramate. BMJ 1999; 318(7187)845
- Patel H., Asconape J. J., Garg B. P. Reversible hemiparesis associated with the use of topiramate. Seizure 2002; 11(7)460–463
- Trimble M. R., Rusch N., Betts T., Crawford P. M. Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables. Seizure 2000; 9(4)249–254
- Khan A., Faught E., Gilliam F., Kuzniecky R. Acute psychotic symptoms induced by topiramate. Seizure 1999; 8(4)235–237
- Matthews S. C., Miller B. P. Auditory hallucinations associated with topiramate. J Clin Psychiatry 2001; 62(8)653
- Jochum T., Bar K. J., Sauer H. Topiramate induced manic episode. J Neurol Neurosurg Psychiatry 2002; 73(2)208–209
- Schlatter F. J., Soutullo C. A., Cervera‐Enguix S. First break of mania associated with topiramate treatment. J Clin Psychopharmacol 2001; 21(4)464–466
- Goldberg J. F. Panic attacks associated with the use of topiramate. J Clin Psychopharmacol 2001; 21(4)461–462
- Klufas A., Thompson D. Topiramate‐induced depression. Am J Psychiatry 2001; 158(10)1736
- Smith A. G., Brauer H. R., Catalano G., Catalano M. C. Topiramate overdose: a case report and literature review. Epilepsy Behav 2001; 2: 603–607
- Fakhoury T., Murray L., Seger D., McLean M., Abou‐Khalil B. Topiramate overdose: clinical and laboratory features. Epilepsy Behav 2002; 3: 185–189
- Markind J. E. Topiramate: a new antiepileptic drug. Am J Health Syst Pharm 1998; 55(6)554–562